ScreenerHero

RVV Revive Therapeutics Ltd.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · revivethera.com
0.0300CAD0.00%Mkt Cap: 7.93M $P/E: —

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap7.93M USD
Enterprise Value9.56M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.02M USD
Revenue/Share—
Last Price0.0300 CAD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA7615161030
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-10.07
EV/Revenue—
P/S—
P/B-3.33
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.005033% of range0.0800
52W High0.0800 CAD
52W Low0.0050 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE318.64%
ROA-5370.77%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-559.06K USD
CapEx (TTM)—
FCF Margin—
FCF Yield2.20%
Net Debt42.32K USD
Net Debt/EBITDA-0.04
Balance Sheet
Debt/Equity-0.02
Current Ratio0.04
Quick Ratio0.02
Book Value/Sh-0.0090 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.435.68M
Float429.35M
Insiders1.51%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short14.37K
Short (prev mo.)33.31K
Technical
SMA 500.0254 (+18.1%)
SMA 2000.0265 (+13.2%)
Beta-1.79
S&P 52W Chg16.45%
Avg Vol (30d)96.99K
Avg Vol (10d)108.83K
Technical Indicators
RSI (14)54.9
MACD-0.0002
MACD Signal-0.0010
MACD Hist.+0.0007
BB Upper0.0316 CAD
BB Middle0.0257 CAD
BB Lower0.0199 CAD
BB Width45.60%
ATR (14)0.0038 CAD
Vol Ratio (20d)1.23x